Novel insights for high mobility group box 1 protein-mediated cellular immune response in sepsis:A systemic review / 世界急诊医学杂志(英文)
World Journal of Emergency Medicine
;
(4): 165-171, 2012.
Article
in English
| WPRIM
| ID: wpr-789562
ABSTRACT
@#BACKGROUND:
High mobility group box 1 protein (HMGB1) is a highly conserved, ubiquitous protein in the nuclei and cytoplasm of nearly all cell types. HMGB1 is secreted into the extracellular milieu and acts as a proinflammatory cytokine. In this article we reviewed briefly the cellular immune response mediated by HMGB1 in inflammation and sepsis.METHODS:
This systemic review is mainly based on our own work and other related reports.RESULTS:
HMGB1 can actively affect the immune functions of many types of cells including T lymphocytes, regulatory T cells (Tregs), dendritic cells (DCs), macrophages, and natural killer cells (NK cells). Various cellular responses can be mediated by HMGB1 which binds to cell-surface receptors [e.g., the receptor for advanced glycation end products (RAGE), Toll-like receptor (TLR)2, and TLR4]. Anti-HMGB1 treatment, such as anti-HMGB1 polyclonal or monoclonal antibodies, inhibitors (e.g., ethyl pyruvate) and antagonists (e.g., A box), can protect against sepsis lethality and give a wider window for the treatment opportunity.CONCLUSION:
HMGB1 is an attractive target for the development of new therapeutic strategies in the treatment of patients with septic complications.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
English
Journal:
World Journal of Emergency Medicine
Year:
2012
Type:
Article
Similar
MEDLINE
...
LILACS
LIS